Reply to A. Wang-Gillam et al.

Autor: Sohal DP; Davendra P.S. Sohal, Cleveland Clinic, Cleveland, OH; Pamela B. Mangu, American Society of Clinical Oncology, Alexandria, VA; Daniel Laheru, Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD; and Alok A. Khorana, Cleveland Clinic, Cleveland, OH., Mangu PB; Davendra P.S. Sohal, Cleveland Clinic, Cleveland, OH; Pamela B. Mangu, American Society of Clinical Oncology, Alexandria, VA; Daniel Laheru, Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD; and Alok A. Khorana, Cleveland Clinic, Cleveland, OH., Laheru D; Davendra P.S. Sohal, Cleveland Clinic, Cleveland, OH; Pamela B. Mangu, American Society of Clinical Oncology, Alexandria, VA; Daniel Laheru, Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD; and Alok A. Khorana, Cleveland Clinic, Cleveland, OH., Khorana AA; Davendra P.S. Sohal, Cleveland Clinic, Cleveland, OH; Pamela B. Mangu, American Society of Clinical Oncology, Alexandria, VA; Daniel Laheru, Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD; and Alok A. Khorana, Cleveland Clinic, Cleveland, OH.
Jazyk: angličtina
Zdroj: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2017 Feb 20; Vol. 35 (6), pp. 690-691. Date of Electronic Publication: 2016 Dec 05.
DOI: 10.1200/JCO.2016.70.7463
Databáze: MEDLINE